Author details

Full Name

Mira Jung

Affiliation

ORCID

Career Start Year

1992

Papers

113

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37586844	Radiotherapy-induced Immune Response Enhanced by Selective HDAC6 Inhibition.	Mol Cancer Ther	2023
35089808	Faster skin wound healing predicts survival after myocardial infarction.	American Journal of Physiology - Heart and Circulatory Physiology	2022
36970725	Novel Paired Normal Prostate and Prostate Cancer Model Cell Systems Derived from African American Patients.	Cancer Res Commun	2022
33127387	Combined high-throughput library screening and next generation RNA sequencing uncover microRNAs controlling human cardiac fibroblast biology.	Journal of Molecular and Cellular Cardiology	2021
33829069	Oxygen Substituted Nucleosides Combined with Proton Beam Therapy: Therapeutic Transmutation In Vitro.	International Journal of Particle Therapy	2021
32649928	Pleiotropic cardiac functions controlled by ischemia-induced lncRNA H19.	Journal of Molecular and Cellular Cardiology	2020
32304626	MiRNA-181a is a novel regulator of aldosterone-mineralocorticoid receptor-mediated cardiac remodelling.	European Journal of Heart Failure	2020
31948273	Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction.	Circulation	2020
30679800	LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML.	Leukemia	2019
31576543	African-American Prostate Normal and Cancer Cells for Health Disparities Research.	Adv Exp Med Biol	2019
31558757	In vivo genome editing using the Cpf1 ortholog derived from Eubacterium eligens.	Scientific Reports	2019
30169632	Exogenous CXCL4 infusion inhibits macrophage phagocytosis by limiting CD36 signalling to enhance post-myocardial infarction cardiac dilation and mortality.	Cardiovascular Research	2019
29285949	Proteomic analysis of the cardiac extracellular matrix: clinical research applications.	Expert Review of Proteomics	2018
29030341	Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing after myocardial infarction.	American Journal of Physiology - Heart and Circulatory Physiology	2018
30510842	Close yet so far away: a look into the management strategies of genetic imprinting disorders.	American Journal of Stem Cells (discontinued)	2018
30523422	Inflammatory cells and their non-coding RNAs as targets for treating myocardial infarction.	Basic Research in Cardiology	2018
28439731	IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation.	Basic Research in Cardiology	2017
28498494	A Mercaptoacetamide-Based Class II Histone Deacetylase Inhibitor Suppresses Cell Migration and Invasion in Monomorphic Malignant Human Glioma Cells by Inhibiting FAK/STAT3 Signaling.	J Cell Biochem	2017
28413032	Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.	Progress in Molecular Biology and Translational Science	2017
28931761	Periodontal-induced chronic inflammation triggers macrophage secretion of Ccl12 to inhibit fibroblast-mediated cardiac wound healing.	JCI insight	2017
28365093	Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps.	Trends in Pharmacological Sciences	2017
27521418	Defining the sham environment for post-myocardial infarction studies in mice.	American Journal of Physiology - Heart and Circulatory Physiology	2016
26890742	A Mercaptoacetamide-Based Class II Histone Deacetylase Inhibitor Increases Dendritic Spine Density via RasGRF1/ERK Pathway.	Journal of Alzheimer's Disease	2016
26825554	Temporal neutrophil polarization following myocardial infarction.	Cardiovascular Research	2016
26721597	Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.	Journal of Molecular and Cellular Cardiology	2016
27208160	MMP-9 signaling in the left ventricle following myocardial infarction.	American Journal of Physiology - Heart and Circulatory Physiology	2016
26100037	Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-ÎºB and STAT activation.		2015
25879388	Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization.	Oncotarget	2015
25361770	Cynandione A attenuates lipopolysaccharide-induced production of inflammatory mediators via MAPK inhibition and NF-ÎºB inactivation in RAW264.7 macrophages and protects mice against endotoxin shock.	Experimental Biology and Medicine	2015
27376092	Using the laws of thermodynamics to understand how matrix metalloproteinases coordinate the myocardial response to injury.		2015
24705373	Protective effect of Disporum sessile D.Don extract against UVB-induced photoaging via suppressing MMP-1 expression and collagen degradation in human skin cells.	Journal of Photochemistry and Photobiology B: Biology	2014
23642045	Functional proteomics analysis to study ATM dependent signaling in response to ionizing radiation.	Radiat Res	2013
23063601	Mercaptoacetamide-based class II HDAC inhibitor lowers AÎ² levels and improves learning and memory in a mouse model of Alzheimer's disease.	Exp Neurol	2013
22836184	Preclinical studies of YK-4-272, an inhibitor of class II histone deacetylases by disruption of nucleocytoplasmic shuttling.	Pharmaceutical Research	2012
22595195	Inhibitory effects of a spinasterol glycoside on lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines via down-regulating MAP kinase pathways and NF-ÎºB activation in RAW264.7 macrophage cells.	International Immunopharmacology	2012
21901627	Histone deacetylase inhibitor: antineoplastic agent and radiation modulator.	Advances in Experimental Medicine and Biology	2011
21370102	Omics-based molecular target and biomarker identification.	Methods Mol Biol	2011
21322649	Integrated analysis of ATM mediated gene and protein expression impacting cellular metabolism.	J Proteome Res	2011
21052099	Combining radiation therapy with interstitial radiation-inducible TNF-Î± expression for locoregional cancer treatment.	Cancer Gene Therapy	2011
21277099	Adamantanyl-histone deacetylase inhibitor H6CAHA exhibits favorable pharmacokinetics and augments prostate cancer radiation sensitivity.	International Journal of Radiation Oncology Biology Physics	2011
21628845	Radiation-generated short DNA fragments may perturb non-homologous end-joining and induce genomic instability.	Journal of Radiation Research	2011
21697394	Histone deacetylase cytoplasmic trapping by a novel fluorescent HDAC inhibitor.	Molecular Cancer Therapeutics	2011
21901628	Human fibroblasts for large-scale "omics" investigations of ATM gene function.	Adv Exp Med Biol	2011
20375073	Modulation of E-cadherin expression by K-Ras; involvement of DNA methyltransferase-3b.	Carcinogenesis	2010
20329776	Analysis of LC-MS data for characterizing the metabolic changes in response to radiation.	J Proteome Res	2010
19789216	Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitors.	Molecular Cancer Therapeutics	2009
19223622	Novel inhibitor of Plasmodium histone deacetylase that cures P. berghei-infected mice.	Antimicrobial Agents and Chemotherapy	2009
19182860	Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.	J Chem Inf Model	2009
19355987	Assays for histone deacetylases.	Current Topics in Medicinal Chemistry	2009
19302790	ATM blocks tunicamycin-induced endoplasmic reticulum stress.	FEBS Letters	2009